Dimensional Fund Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-74,826
| Closed | -$171K | – | 3401 |
|
|
2024
Q2 | $171K | Sell |
74,826
-2,705
| -3% | -$10.3K | ﹤0.01% | 3189 |
|
|
2024
Q1 | $335K | Buy |
77,531
+865
| +1% | +$3.01K | ﹤0.01% | 3119 |
|
|
2023
Q4 | $234K | Buy |
76,666
+2,258
| +3% | +$4.24K | ﹤0.01% | 3170 |
|
|
2023
Q3 | $107K | Sell |
74,408
-8,843
| -11% | -$17.1K | ﹤0.01% | 3307 |
|
|
2023
Q2 | $207K | Sell |
83,251
-5,882
| -7% | -$16.1K | ﹤0.01% | 3232 |
|
|
2023
Q1 | $239K | Sell |
89,133
-278,836
| -76% | -$1.34M | ﹤0.01% | 3164 |
|
|
2022
Q4 | $2K | Sell |
367,969
-98,461
| -21% | -$825K | ﹤0.01% | 2728 |
|
|
2022
Q3 | $5.83M | Sell |
466,430
-71,557
| -13% | -$817K | ﹤0.01% | 2376 |
|
|
2022
Q2 | $2.66M | Sell |
537,987
-28,024
| -5% | -$155K | ﹤0.01% | 2655 |
|
|
2022
Q1 | $4.3M | Buy |
566,011
+41,278
| +8% | +$391K | ﹤0.01% | 2581 |
|
|
2021
Q4 | $5.36M | Sell |
524,733
-64,598
| -11% | -$823K | ﹤0.01% | 2542 |
|
|
2021
Q3 | $7.91M | Sell |
589,331
-480,793
| -45% | -$7.83M | ﹤0.01% | 2427 |
|
|
2021
Q2 | $23.5M | Buy |
1,070,124
+225,057
| +27% | +$5M | 0.01% | 1976 |
|
|
2021
Q1 | $20.4M | Buy |
845,067
+251,613
| +42% | +$5.85M | 0.01% | 2027 |
|
|
2020
Q4 | $10.7M | Sell |
593,454
-1,053
| -0.2% | -$15.7K | ﹤0.01% | 2254 |
|
|
2020
Q3 | $6.87M | Buy |
594,507
+14,297
| +2% | +$236K | ﹤0.01% | 2356 |
|
|
2020
Q2 | $14.1M | Buy |
580,210
+38,985
| +7% | +$645K | 0.01% | 2052 |
|
|
2020
Q1 | $5.96M | Buy |
541,225
+9,811
| +2% | +$183K | ﹤0.01% | 2338 |
|
|
2019
Q4 | $14M | Buy |
531,414
+147,240
| +38% | +$3.44M | 0.01% | 2208 |
|
|
2019
Q3 | $8.76M | Buy |
384,174
+56,755
| +17% | +$1.79M | ﹤0.01% | 2397 |
|
|
2019
Q2 | $10M | Buy |
327,419
+82,460
| +34% | +$1.74M | ﹤0.01% | 2394 |
|
|
2019
Q1 | $4.07M | Buy |
244,959
+162,989
| +199% | +$3.09M | ﹤0.01% | 2710 |
|
|
2018
Q4 | $1.57M | Buy |
+81,970
| New | +$3.07M | ﹤0.01% | 2929 |
|
Dimensional Fund Advisors's GTHX Position: Q3 2024 in Review
Dimensional Fund Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 74,826 shares — an estimated $171K sold.
Dimensional Fund Advisors first reported a position in GTHX in Q4 2018 and held it in 23 quarters. The position peaked at $23.5M in Q2 2021. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- Dimensional Fund Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Dimensional Fund Advisors sold 74,826 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $171K.
- Dimensional Fund Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2018 and held it in 23 quarters.
- Dimensional Fund Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $23.5M in Q2 2021.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.
Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.